KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Authorities in the Democratic Republic of the Congo have initiated a targeted vaccination effort against Ebola in Kisangani, the administrative center of Tshopo Province, aiming to halt the nation’s most severe outbreak on record. Frontline health professionals, emergency responders, and individuals with direct contact to confirmed cases are prioritized during the initial deployment phase. Health Minister Roger Kamba stated that the government launched the vaccination campaign using doses of the Ervebo vaccine to protect frontline workers operating across affected eastern regions.
Official epidemiological reports reveal that the ongoing outbreak has affected six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Data released by the Ministry of Public Health and Prevention indicates that the country has registered 5,713 confirmed cases and 2,744 fatalities. The current case fatality rate among confirmed patients is approximately 48%.
International health organizations, such as the World Health Organization, have stepped in to assist local health teams with logistical support, laboratory testing, and vaccine distribution efforts. Vaccine administration is occurring under a compassionate-use framework as medical researchers observe the vaccine’s effectiveness against the circulating viral strain. DR Congo’s new vaccination initiative is part of an intensified ring-vaccination strategy aimed at containing viral transmission clusters.
DR Congo Implements Vaccination Program Throughout Key Eastern Regions
Operational challenges include difficult regional infrastructure, ongoing security issues, and high mobility of populations across border districts, complicating logistics. Kisangani has established cold-chain supply systems to preserve the ultra-low temperatures necessary for vaccine storage before distribution to remote health zones. The Ebola vaccination campaign is underway as civil defense and community health workers engage in outreach programs to bolster disease surveillance and reporting efforts.
Epidemiologists from the Africa Centres for Disease Control and Prevention are collaborating with local teams to monitor adverse reactions and assess immune responses among vaccinated populations. Officials highlight that prompt clinical detection, combined with isolation measures and supportive treatments, are vital to improving patient survival rates. Additional vaccine consignments are planned for delivery as regional distribution broadens across secondary health districts.
Kisangani Serves as Central Hub for the Distribution of Vaccines in the Region
National response teams continue expanding contact-tracing efforts across urban and rural areas within the eastern provinces. Local health clinics are receiving protective gear, diagnostic reagents, and treatment supplies to enhance preparedness. The government confirmed that public health measures will stay in place until data shows a consistent decline in transmission rates across all affected regions.
Officials called on local communities to cooperate fully with mobile vaccination units and follow hygiene protocols. It is anticipated that increasing vaccine coverage among high-risk populations will help stabilize infection numbers in the upcoming weeks. Surveillance systems will keep close watch over transportation hubs and border crossings to prevent further geographic spread.